The use of hepatitis B immunoglobulin in the Netherlands
- PMID: 54274
Item in Clipboard
The use of hepatitis B immunoglobulin in the Netherlands
Dev Biol Stand.
1975.
Abstract
Hepatitis B immunoglobulin (HBIg) was administered to 241 patients contaminated with HBAg positive material; 116 persons were followed up for 7 months after the HBIg injection. Only 4 (3.4%) cases of hepatitis B with jaundice and demonstrable HBAg occurred and 15 (12.9%) cases of subclinical hepatitis B were observed. HBIg is well tolerated. Passively transferred HBAb were demonstrable for 2-3 months and no chronic carriers of HBAg were seen after administration of HBIg.
Similar articles
-
[Frequency of antigen associated to hepatitis due to virus B (HBAg) and of antibody (HBAc) in healthy subjects and during of course of acute and chronic hepatitis. Radioimmunologic study].Quad Sclavo Diagn. 1975 Jun;11(2):419-30. Quad Sclavo Diagn. 1975. PMID: 1223946 Italian.
-
Hepatitis B immune serum globulin in prevention of hepatitis B among hospital personnel. Preliminary report from a controlled trial.Dev Biol Stand. 1975;30:305-9. Dev Biol Stand. 1975. PMID: 54273 Clinical Trial.
-
Prevention of hepatitis B in hemodialysis patients using hepatitis B immunoglobulin. A controlled study.Clin Nephrol. 1977 Sep;8(3):373-6. Clin Nephrol. 1977. PMID: 912951 Clinical Trial.
-
Viral hepatitis--the state of the art.Med Trial Tech Q. 1974 Summer;21(1):63-75. Med Trial Tech Q. 1974. PMID: 4138562 Review. No abstract available.
-
Viral markers of hepatitis.Lab Res Methods Biol Med. 1983;7:103-17. Lab Res Methods Biol Med. 1983. PMID: 6413796 Review. No abstract available.
MeSH terms
Substances
LinkOut - more resources
Research Materials